The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review
Open accessAbstract
Immune thrombocytopenia, often known as immune thrombocytopenic purpura (ITP), has emerged as an important complication of COVID-19. A systematic review was done to analyze the clinical profile and outcomes in a total of 45 cases of new-onset ITP in COVID-19 patients described in literature until date. A comprehensive approach is essential for diagnosing COVID-19-associated ITP after excluding several concomitant factors that can cause thrombocytopenia in COVID-19. Majority of ITP cases (71%) were found to be elderly (> 50 years) and 75% cases had moderate-to-severe COVID-19. Three patients (7%) were in the pediatric age group. Reports of ITP in asymptomatic COVID-19 patients (7%) underscore the need for COVID-19 testing in newly diagnosed patients with ITP irrespective of COVID-19 symptoms amid this pandemic. ITP onset occurred in 20% cases 3 weeks after onset of COVID-19 symptoms, with many reports after clinical recovery. SARS-CoV-2-mediated immune thrombocytopenia can be attributed to the underlying immune dysregulation, susceptibility mutations in SOCS 1, and other mechanisms, including molecular mimicry, cryptic antigen expression, and epitope spreading. No bleeding manifestations were reported in 31% cases at diagnosis. Severe life-threatening bleeding was uncommon. One case of mortality was attributed to intracranial hemorrhage. Secondary Evans syndrome was diagnosed in one case. Good initial response to short course of glucocorticoids and intravenous immunoglobulin has been found with the exception of delayed lag response in one case. Thrombopoietin receptor agonist usage as a second-line agent has been noted in few cases for short duration with no adverse events. In the relatively short follow-up period, four relapses of ITP were found.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D. M., Bussel, J. B., Cines, D. B., Chong, B. H., Cooper, N., et al. (2009) · Blood · doi:10.1182/blood-2008-07-162503 · Cited by 2,690
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Neunert, C., Terrell, D. R., Arnold, D. M., Buchanan, G., Cines, D. B., Cooper, N., Cuker, A., Despotovic, J. M., George, J. N., Grace, R. F., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000966 · Cited by 1,406
Platelet gene expression and function in patients with COVID-19
Manne, B. K., Denorme, F., Middleton, E. A., Portier, I., Rowley, J. W., Stubben, C., Petrey, A. C., Tolley, N. D., Guo, L., Cody, M., et al. (2020) · Blood · doi:10.1182/blood.2020007214 · Cited by 946
Mechanism of thrombocytopenia in COVID-19 patients
Xu, P., Zhou, Q., & Xu, J. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04019-0 · Cited by 578
Cuker, A., Gimotty, P. A., Crowther, M. A., & Warkentin, T. E. (2012) · Blood · doi:10.1182/blood-2012-07-443051 · Cited by 479
Heparin-induced thrombocytopenia
Arepally, G. M. (2017) · Blood · doi:10.1182/blood-2016-11-709873 · Cited by 442
Platelets and Infection – An Emerging Role of Platelets in Viral Infection
Assinger, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00649 · Cited by 386
Cited by
Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination
Lee, E., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., Semple, J. W., Arnold, D. M., Godeau, B., Lambert, M. P., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26132 · Cited by 388
Rogue antibodies could be driving severe COVID-19
Khamsi, R. (2021) · Nature · doi:10.1038/d41586-021-00149-1 · Cited by 91
Gordon, S. F., Clothier, H. J., Morgan, H., Buttery, J. P., Phuong, L. K., Monagle, P., Chunilal, S., Wood, E. M., Tran, H., Szer, J., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.10.030 · Cited by 28
Metadata
- Authors
- Bhattacharjee, S., & Banerjee, M.
- Venue
- SN Comprehensive Clinical Medicine
- Published
- 2020-09-19
- Volume
- 2
- Issue
- 11
- Pages
- 2048-2058
- ISSN
- 2523-8973 (ISSN-L)
- OpenAlex
- W3087313970
- Cited by
- 287
- References
- 43
- FWCI
- 15.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review. https://app.cochat.ai/papers/10.1007/s42399-020-00521-8
- The paper
- Bhattacharjee, S., & Banerjee, M. (2020). Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review. SN Comprehensive Clinical Medicine. https://doi.org/10.1007/s42399-020-00521-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.